Clostridium septicum: Difference between revisions
From IDWiki
Clostridium septicum
No edit summary |
(added dosing) |
||
| Line 16: | Line 16: | ||
* Aggressive surgical debridement, possibly including amputation |
* Aggressive surgical debridement, possibly including amputation |
||
* Broad-spectrum antibiotics for [[necrotizing fasciitis]] are indicated until the microbiologic diagnosis is confirmed |
* Broad-spectrum antibiotics for [[necrotizing fasciitis]] are indicated until the microbiologic diagnosis is confirmed |
||
* First-line antimicrobials are [[Is treated by::penicillin]] plus [[Is treated by::clindamycin]] |
* First-line antimicrobials are [[Is treated by::penicillin]] 2-4 million units IV q4h plus [[Is treated by::clindamycin]] 600-900 mg IV q6h |
||
{{DISPLAYTITLE:''Clostridium septicum''}} |
{{DISPLAYTITLE:''Clostridium septicum''}} |
||
Revision as of 21:20, 13 April 2020
Background
Microbiology
- Gram-positive bacillus
- Member of the genus Clostridium
- Produces alpha toxin
Risk factors
- Associated with colon cancer or neutropenia
- Diabetes also a risk factor
Clinical Presentation
- Can cause bacteremia and non-traumatic myonecrosis
- Clinical presentation is typically fulminant sepsis, which very high mortality
Management
- Aggressive surgical debridement, possibly including amputation
- Broad-spectrum antibiotics for necrotizing fasciitis are indicated until the microbiologic diagnosis is confirmed
- First-line antimicrobials are penicillin 2-4 million units IV q4h plus clindamycin 600-900 mg IV q6h
